Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy

Open Access

Peer-reviewed

Research Article

Krithika N. Kodumudi,

Affiliation Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, SRB-3, Room 24314, Tampa, FL, 33612, United States of America
⨯
Jessica Siegel,

Affiliation Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, SRB-3, Room 24314, Tampa, FL, 33612, United States of America
⨯
Amy M. Weber,

Affiliation Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, SRB-3, Room 24314, Tampa, FL, 33612, United States of America
⨯
Ellen Scott,

Affiliation Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, SRB-3, Room 24314, Tampa, FL, 33612, United States of America
⨯
Amod A. Sarnaik,

Affiliation Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, SRB-3, Room 24314, Tampa, FL, 33612, United States of America
⨯
Shari Pilon-Thomas

* E-mail: Shari.Pilon-Thomas@moffitt.org

Affiliation Department of Immunology, Moffitt Cancer Center, 12902 Magnolia Drive, SRB-3, Room 24314, Tampa, FL, 33612, United States of America
⨯

Reader Comments (0)

Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Antibody therapy
Is the Subject Area "Antibody therapy" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Cytotoxic T cells
Is the Subject Area "Cytotoxic T cells" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.